Literature DB >> 35771418

A Three-Dimensional Culture-Based Assay to Detect Early Stages of Vasculogenic Mimicry in Ovarian Cancer Cells.

Yarely M Salinas-Vera1, Dolores Gallardo-Rincón2, Erika Ruíz-García2, Laurence A Marchat3, Jesús Valdés1, Carlos Vázquez-Calzada4, César López-Camarillo5.   

Abstract

Vasculogenic mimicry is a cellular mechanism in which tumor cells grow and align forming complex three-dimensional (3D) channel-like structures in a hypoxic microenvironment. This phenomenon represents a novel oxygen, nutrient, and blood supply, in a similar way as occurs in classic angiogenesis. Vasculogenic mimicry has been described in numerous clinical tumors including breast, prostate, lung, and ovarian cancers where it is associated with poor prognosis; thus, it is considered as a hallmark of highly aggressive and metastatic tumors. Here, we describe a simple method to model the in vitro formation of three-dimensional cellular networks over Matrigel in SKOV3 ovarian cancer cells representing the early stages of vasculogenic mimicry.
© 2022. Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Engelbreth; Holm; Ovarian cancer; Swarm extracellular matrix extract; Three-dimensional culture; Vasculogenic mimicry; miR-765; microRNAs

Mesh:

Year:  2022        PMID: 35771418     DOI: 10.1007/978-1-0716-2403-6_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

2.  Cooperative multi-targeting of signaling networks by angiomiR-204 inhibits vasculogenic mimicry in breast cancer cells.

Authors:  Yarely M Salinas-Vera; Laurence A Marchat; Raúl García-Vázquez; Claudia Haydée González de la Rosa; Eduardo Castañeda-Saucedo; Napoleón Navarro Tito; Carlos Palma Flores; Carlos Pérez-Plasencia; José L Cruz-Colin; Ángeles Carlos-Reyes; José Sullivan López-González; María Elizbeth Álvarez-Sánchez; César López-Camarillo
Journal:  Cancer Lett       Date:  2018-06-06       Impact factor: 8.679

3.  Recent progress in the diagnosis and treatment of ovarian cancer.

Authors:  Danijela Jelovac; Deborah K Armstrong
Journal:  CA Cancer J Clin       Date:  2011-04-26       Impact factor: 508.702

Review 4.  Epidemiology of epithelial ovarian cancer.

Authors:  Penelope M Webb; Susan J Jordan
Journal:  Best Pract Res Clin Obstet Gynaecol       Date:  2016-10-03       Impact factor: 5.237

5.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

Authors:  A J Maniotis; R Folberg; A Hess; E A Seftor; L M Gardner; J Pe'er; J M Trent; P S Meltzer; M J Hendrix
Journal:  Am J Pathol       Date:  1999-09       Impact factor: 4.307

6.  Ovarian cancer.

Authors:  Bryan T Hennessy; Robert L Coleman; Maurie Markman
Journal:  Lancet       Date:  2009-09-28       Impact factor: 79.321

Review 7.  New strategies in the treatment of ovarian cancer: current clinical perspectives and future potential.

Authors:  Susana Banerjee; Stanley B Kaye
Journal:  Clin Cancer Res       Date:  2013-01-10       Impact factor: 12.531

8.  Short-term anti-vascular endothelial growth factor treatment elicits vasculogenic mimicry formation of tumors to accelerate metastasis.

Authors:  Yuan Xu; Qin Li; Xiao-Yu Li; Qiu-Ya Yang; Wei-Wei Xu; Gao-Lin Liu
Journal:  J Exp Clin Cancer Res       Date:  2012-02-23

Review 9.  Angiogenesis and vasculogenic mimicry as therapeutic targets in ovarian cancer.

Authors:  Dansaem Lim; Yeojin Do; Byung Su Kwon; Woochul Chang; Myeong-Sok Lee; Jongmin Kim; Jin Gu Cho
Journal:  BMB Rep       Date:  2020-06       Impact factor: 4.778

10.  HypoxamiRs Profiling Identify miR-765 as a Regulator of the Early Stages of Vasculogenic Mimicry in SKOV3 Ovarian Cancer Cells

Authors:  Yarely M Salinas-Vera; Dolores Gallardo-Rincón; Raúl García-Vázquez; Olga N Hernández-de la Cruz; Laurence A Marchat; Juan Antonio González-Barrios; Erika Ruíz-García; Carlos Vázquez-Calzada; Estefanía Contreras-Sanzón; Martha Resendiz-Hernández; Horacio Astudillo-de la Vega; José L Cruz-Colin; Alma D Campos-Parra; César López-Camarillo
Journal:  Front Oncol       Date:  2019-05-14       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.